Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule. [electronic resource]
Producer: 20000428Description: 155-62 p. digitalISSN:- 0888-0018
- Adolescent
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Child
- Child, Preschool
- Cytogenetics
- Dexamethasone -- therapeutic use
- Disease-Free Survival
- Disseminated Intravascular Coagulation -- chemically induced
- Drug Administration Schedule
- Female
- Fibrin Fibrinogen Degradation Products -- metabolism
- Fibrinogen -- metabolism
- Hemorrhage -- drug therapy
- Hemorrhagic Disorders -- prevention & control
- Humans
- Leukemia, Promyelocytic, Acute -- drug therapy
- Male
- Platelet Count
- Retrospective Studies
- Risk Factors
- Survival
- Time Factors
- Tretinoin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.